Adventia NIPD GENETICS Carrier Screening

WIPO WIPO 2020

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark Adventia NIPD GENETICS Carrier Screening was filed as Figurative mark on 06/12/2020 at the World Intellectual Property Organization.

Logodesign (Wiener Klassifikation)

#Letters presenting a special form of writing #Colours #Series of letters presenting different forms of writing #Series of letters in different dimensions #Two predominant colours

Trademark Details Last update: November 15, 2022

Trademark form Figurative mark
File reference 1544123
Register number 018191796
Countries Israel India Japan Serbia Russia Singapore Turkey Ukraine United States of America (USA)
Base trademark EU No. 018191796, June 3, 2020
Application date June 12, 2020
Expiration date June 12, 2030

Trademark owner

31, Neas Engomis, Engomi
2409 Nicosia
CY

Trademark representatives

2-4, Arch. Makaros III Avenue, Capital Center, 7th floor CY

goods and services

01 Kits composed of reagents for genetic testing for medical and scientific research purposes; kits composed of reagents for genetic testing for medical and scientific research purposes in the field of human reproduction; kits composed of reagents for testing prospective parents for medical and scientific research purposes; kits composed of reagents for testing the carrier status of prospective parents for gene mutations with or without evident phenotype for medical and scientific research purposes
42 Medical laboratory services for carrier testing of prospective parents for genetic abnormalities; design and development of medical screening tests and products; medical and scientific research in the field of genetic testing; providing medical and scientific research information in the field of genetic testing; genetic testing for scientific research and analysis purposes in the field of human reproduction; carrier testing of prospective parents for scientific research purposes; testing for sub-chromosomal abnormalities and genetic mutations in prospective parents for research purposes; scientific, laboratory, clinical, medical, and technological research and analysis services in the fields of genetic testing in prospective parents
44 Medical postnatal testing services for screening of prospective parents for genetic abnormalities; medical genetic screening testing of prospective parents; medical testing of biological material for screening prospective parents for genetic abnormalities prior to pregnancy; medical testing of buccal swab for screening of the carrier status for genetic abnormalities in prospective parents; genetic testing and genetic counseling in the field of human reproduction; medical and health services relating to dna, genetics and genetic testing

Trademark history

Date Document number Area Entry
August 5, 2021 2021/31 Gaz JP Rejection
July 26, 2021 2021/30 Gaz UA Rejection
July 1, 2021 2021/27 Gaz US RAW: Rule 18ter(2)(ii) GP following a provisional refusal
March 17, 2021 2021/13 Gaz SG RAW: Rule 18ter(2)(ii) GP following a provisional refusal
March 8, 2021 2021/10 Gaz IN Rejection
March 5, 2021 2021/10 Gaz IL Rejection
March 1, 2021 2021/9 Gaz RU RAW: Rule 18ter(2)(ii) GP following a provisional refusal
February 4, 2021 2021/6 Gaz RS Rejection
December 23, 2020 2020/53 Gaz TR Rejection
November 27, 2020 2020/50 Gaz RU Rejection
October 31, 2020 2020/45 Gaz SG Rejection
October 1, 2020 2020/40 Gaz US Rejection
June 12, 2020 2020/30 Gaz EM Registration

ID: 141544123